Attached files

file filename
8-K - 8-K - AV Therapeutics, Inc.avtherapeutics8k040715.htm
Exhibit 16.1



April 7, 2015


U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, DC  20549

Commissioners:

We have read the statements made by AV Therapeutics, Inc. under Item 4.01 of its Form 8-K dated April 7, 2015.  We agree with the statements concerning our Firm in such Form 8-K; we are not in a position to agree or disagree with other statements of AV Therapeutics, Inc. contained therein.

Very truly yours,


/s/ Marcum llp